微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 39.19% | -0.16% | -2.22% | 26/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 40.08% | 0.51% | 5.91% | 23/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 37.84% | 3.88% | -4.91% | 26/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 39.79% | 7.99% | 1.37% | 28/51 | 38.12% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 39.25% | 4.81% | -1.55% | 31/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 39.87% | 3% | 9.46% | 28/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 36.42% | -3.79% | -1.14% | 32/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 36.85% | -3.86% | -1.62% | 37/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 37.45% | 2% | -3.25% | 31/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 38.71% | -3.93% | 2.25% | 31/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 37.86% | 2% | -1.22% | 29/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 38.32% | -2.37% | -4.89% | 35/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-06-30 | 40.29% | -3.91% | 2.65% | 28/51 | 42.6% | 南华生物 | 84.53% | 行业排名> |
| 2020-12-31 | 39.25% | -9.77% | -6.39% | 32/51 | 38.51% | 南华生物 | 83.19% | 行业排名> |
| 2020-06-30 | 41.93% | 2% | -3.61% | 20/51 | 39.28% | 南华生物 | 83.9% | 行业排名> |
| 2019-12-31 | 43.5% | 15.32% | 15.32% | 22/51 | 42.94% | 成都先导 | 79.36% | 行业排名> |
| 2018-12-31 | 37.72% | 4.32% | 4.32% | 31/51 | 42.09% | 成都先导 | 75.92% | 行业排名> |
| 2017-12-31 | 36.16% | 2% | 2% | 27/51 | 40.94% | 南华生物 | 78.74% | 行业排名> |